ABT Stock Analysis: Buy, Sell, or Hold?
ABT - Abbott Laboratories
$103.35
-0.64 (-0.62%)
▼
5d:
-1.43%
30d:
-11.17%
90d:
-17.21%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Apr 16, 2026
16d
Get Alerted When ABT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ABT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ABT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$175.64
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$109.06
5.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ABT is currently trading at $103.35, which is considered oversold relative to its 30-day fair value range of $106.65 to $114.20. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.0) compared to its historical average (19.6). Remarkably, the market is currently pricing in an annual earnings decline of 4.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ABT is in a strong downtrend. The price is currently testing key support at $102.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ABT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $132.64 (+27.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABT is in a strong downtrend. The price is currently testing key support at $102.41. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ABT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $132.64 (+27.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$106.65 -
$114.20
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding ABT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 27.6% below Wall St target ($132.64)
Fair Price Analysis
30-Day Fair Range
$106.65 -
$114.20
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$102.41
Resistance Level
$111.86
Current Trend
Strong Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.98
Wall Street Target
$132.64
(+27.6%)
Revenue Growth (YoY)
4.4%
Earnings Growth (YoY)
-80.9%
Profit Margin
14.7%
Valuation Discount vs History
-4.7% cheaper
PE vs Historical
17.0 vs 19.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.7%
(market-implied from PE analysis)
1-Year Target
$99.10
(-5%)
2-Year Target
$94.44
(-9%)
3-Year Target
$90.01
(-13%)
3-Yr Target (if PE normalizes)
(PE: 17→20)
$103.88
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 11.9%)
$192.06
(+85%)
Base:
(SPY PE: 17.0, Growth: 11.9%)
$145.61
(+40%)
Bear:
(PE: 14.4, Growth: 11.9%)
$123.77
(+19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 28.35 | Current EPS (TTM): $3.72
Bull Case
$194.62
(+86%)
Analyst growth 67.8%, PE expands to 31.2
Base Case
$176.93
(+69%)
Market implied 67.8%, PE stable at 28.4
Bear Case
$71.71
(-32%)
Severe decline -20.0%, PE contracts to 24.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.0 to 19.6
Stabilization Target:
$120.02
(+15.4%)
PE Expansion Potential:
+15.4%
Share & Embed Analysis
Last updated: March 30, 2026 9:59 AM ET
Data refreshes hourly during market hours. Next update: 10:59 AM
Data refreshes hourly during market hours. Next update: 10:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABT showing a specific setup today?
Insider Activity (6 Months)
4
Buys
16
Sells
Net
INSIDERS SELLING
Recent Transactions
Elizabeth C Cushman
SELL
263 shares
2026-03-02
Daniel Gesua Sive Salvad…
SELL
885 shares
2026-03-02
Mary K Moreland
SELL
613 shares
2026-03-02
Featured in Portfolios
ABT is a key holding in these high-performance investment strategies.
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 48 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 58 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 56 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$103 | 57 HOLD |
Advanced ABT Option Strategies
Professional options setups generated by AI based on today's ABT price and gamma walls.
